Panacea Life Sciences Holdings, Inc. Notes Payable, Current
Panacea Life Sciences Holdings, Inc. (PLSH) had Notes Payable, Current of $10.83 million as of 2023-06-30, per its 10-Q filed 2023-08-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2023-08-15
- 2023-06-30: Notes Payable, Current $10.83M.
- 2023-03-31: Notes Payable, Current $10.40M.
- 2022-12-31: Notes Payable, Current $9.87M.
- 2021-03-31: Notes Payable, Current $209.82K; Notes Payable, Current as first filed $130.34K.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2023-06-30 | $10.83M 10-Q · filed 2023-08-15 | |
| 2023-03-31 | $10.40M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $9.87M 10-Q · filed 2023-08-15 | |
| 2021-03-31 | $209.82K 10-Q/A · filed 2021-05-27 | $130.34K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $130.34K 10-Q/A · filed 2021-05-27 | |
| 2020-09-30 | $130.34K 10-Q · filed 2020-11-18 | |
| 2020-06-30 | $90.75K 10-Q · filed 2020-08-19 | |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-23 |